Dongwha Pharm.Co.,Ltd (000020.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

6.2x

Market Cap

KRW 145.24B

MomentumView details →

1D Return

+0.78%

YTD Return

−16.64%

RSI (14)

53.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

6.2x

Market Cap

KRW 145.24B

RSI (14)

53.3

MomentumView details →

1D Return

+0.78%

YTD Return

−16.64%

ProfitabilityView details →

Gross Margin

41.84%

Net Margin

3.52%

EBITDA Margin

8.11%

ROE (TTM)

4.58%

ROA (TTM)

2.77%

Asset Turnover

0.79x

GrowthView details →

Revenue YoY

−15.47%

EPS YoY

+185.75%

FCF YoY

+96.41%

Revenue CAGR 3Y

+13.40%

EPS CAGR 3Y

−24.78%

EBITDA YoY

−77.64%

EarningsView details →

EPS (Actual)

KRW 239.74

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

99.61%

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

1.22x

Quick Ratio

0.70x

Div Yield

4.71%

Div Rate

KRW 245.00

Div Growth 1Y

−63.89%

Financials snapshotView financials →

Revenue (TTM)

513.24B

Net Income (TTM)

18.08B

Op. CF (TTM)

27.37B

Latest newsMore news →

No recent news for 000020.KS.

Similar companies

Hana Pharm Co., Ltd.293480.KS HANDOK Inc.002390.KS Daihan Pharmaceutical Co.,Ltd.023910.KQ Kyongbo Pharmaceutical Co., Ltd214390.KS Samil Pharmaceutical Co.,Ltd000520.KS BNC Korea Co., Ltd.256840.KQ Find similar companies →

Latest newsMore news →

No recent news for 000020.KS.